The Chemours Company – NYSE:CC
The Chemours Company stock price today
$15.38
-1.63
-9.58%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
The Chemours Company stock price monthly change
-30.60%
month
The Chemours Company stock price quarterly change
-30.60%
quarter
The Chemours Company stock price yearly change
-47.61%
year
The Chemours Company key metrics
Market Cap | 2.61B |
Enterprise value | 6.23B |
P/E | 36.90 |
EV/Sales | 1.08 |
EV/EBITDA | 10.92 |
Price/Sales | 0.44 |
Price/Book | 3.87 |
PEG ratio | 0.36 |
EPS | -2.21 |
Revenue | 5.84B |
EBITDA | 46M |
Income | -330M |
Revenue Q/Q | -12.10% |
Revenue Y/Y | -11.04% |
Profit margin | 1.2% |
Oper. margin | 6.52% |
Gross margin | 19.53% |
EBIT margin | 6.52% |
EBITDA margin | 0.79% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeThe Chemours Company stock price history
The Chemours Company stock forecast
The Chemours Company financial statements
Average Price Target
$30
Potential upside: 95.05%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 1.64B | -376M | -22.88% |
|---|---|---|---|
| Sep 2023 | 1.48B | 20M | 1.34% |
| Dec 2023 | 1.36B | -26M | -1.91% |
| Mar 2024 | 1.35B | 52M | 3.85% |
Paying a dividend greater than earnings.
5.87%
Yield TTM
| Payout ratio | 215.94% |
|---|
| 2019 | 5.5% |
|---|---|
| 2020 | 4.02% |
| 2021 | 2.96% |
| 2022 | 3.24% |
| 2023 | 3.17% |
| Jun 2023 | 7660000000 | 6.85B | 89.43% |
|---|---|---|---|
| Sep 2023 | 7948000000 | 7.19B | 90.48% |
| Dec 2023 | 8251000000 | 7.51B | 91.04% |
| Mar 2024 | 7978000000 | 7.22B | 90.55% |
| Jun 2023 | 61M | -60M | -73M |
|---|---|---|---|
| Sep 2023 | 130M | 58M | 325M |
| Dec 2023 | 484M | -130M | -7M |
| Mar 2024 | -290M | -101M | -54M |
The Chemours Company alternative data
| Sep 2023 | 6,600 |
|---|---|
| Oct 2023 | 6,600 |
| Nov 2023 | 6,600 |
| Dec 2023 | 6,600 |
| Jan 2024 | 6,600 |
| Feb 2024 | 6,600 |
| Mar 2024 | 6,600 |
| Apr 2024 | 6,600 |
| May 2024 | 6,200 |
| Jun 2024 | 6,200 |
| Jul 2024 | 6,200 |
The Chemours Company other data
68.08%
-1.58%
of CC is owned by hedge funds
450
-28
114.85M
-2.84M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Aug 2024 | 0 | 2757 |
| Nov 2024 | 0 | 7500 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | SCARBOROUGH ALVENIA officer: SVP Corp Communication.. | Common Stock | 7,500 | $20.64 | $154,770 | ||
Sale | PICHO DIANE I. officer: Interim Pres. - Titani.. | Common Stock | 1,576 | $18.81 | $29,645 | ||
Sale | PICHO DIANE I. officer: Interim Pres. - Titani.. | Common Stock | 1,108 | $18.84 | $20,875 | ||
Sale | PICHO DIANE I. officer: Interim Pres. - Titani.. | Common Stock | 73 | $19.04 | $1,390 | ||
Option | SCARBOROUGH ALVENIA officer: SVP Corp Communication.. | Common Stock | 5,125 | $14.43 | $73,954 | ||
Sale | SCARBOROUGH ALVENIA officer: SVP Corp Communication.. | Common Stock | 5,125 | $32.3 | $165,537 | ||
Option | SCARBOROUGH ALVENIA officer: SVP Corp Communication.. | Stock Option (Right to Buy) | 5,125 | $14.43 | $73,954 | ||
Purchase | NEWMAN MARK director, officer.. | Common Stock | 15,322 | $33.63 | $515,279 | ||
Option | ABBOTT MATTHEW S officer: SVP, Chi.. | Common Stock | 8,912 | $14.43 | $128,600 | ||
Sale | ABBOTT MATTHEW S officer: SVP, Chi.. | Common Stock | 8,912 | $34.2 | $304,790 |
| Patent |
|---|
Grant Filling date: 22 Jan 2021 Issue date: 13 Sep 2022 |
Grant Utility: Aqueous polymerization of fluorinated monomer using polymerization agent comprising fluoropolyether acid or salt and short chain fluorosurfactant Filling date: 13 Aug 2013 Issue date: 13 Sep 2022 |
Application Filling date: 11 Aug 2020 Issue date: 8 Sep 2022 |
Application Filling date: 16 Jul 2020 Issue date: 8 Sep 2022 |
Grant Filling date: 31 Mar 2021 Issue date: 6 Sep 2022 |
Grant Utility: Compositions, system and methods for introducing PAG lubricant or refrigerant into an air-conditioning or system using lower or low GWP refrigerant or refrigerant blends Filling date: 5 Jan 2021 Issue date: 30 Aug 2022 |
Application HFO-1234ZE, HFO-1225ZC AND HFO-1234YF COMPOSITIONS AND PROCESSES FOR PRODUCING AND USING THE COMPOSITIONS Filling date: 29 Apr 2022 Issue date: 25 Aug 2022 |
Application Filling date: 21 Aug 2020 Issue date: 25 Aug 2022 |
Application CONVERSION OF CHLOROFLUOROROPANES AND CHLOROFLUROPROPENES TO MORE DESIRABLE FLUOROPROPANES AND FLUOROROPENES Filling date: 18 Apr 2022 Issue date: 28 Jul 2022 |
Application Filling date: 23 Jun 2020 Issue date: 28 Jul 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 1 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 28 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 27 Oct 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 28 Jul 2023 | Q2 2023 Earnings Call Transcript |
Chemours: Upside After Irregularities, Good 2024-2026E
Chemours: Technological Innovation Presents Excellent Opportunities For Growth
ChampionX: Short Term And Long Term Catalysts
Chemours - There Is Upside After A Drop In Share Price
Kronos Worldwide: Depressed Cyclical At Below Replacement Value
Tronox: May Not Produce Adequate Returns
Chemours: Time To Revisit And It's A 'Buy'
Energy Fuels: Alta Mesa Deal Should Help The Stock
Chemours: The Wrong Call Before, But Now A 'Buy'
-
What's the price of The Chemours Company stock today?
One share of The Chemours Company stock can currently be purchased for approximately $15.38.
-
When is The Chemours Company's next earnings date?
Unfortunately, The Chemours Company's (CC) next earnings date is currently unknown.
-
Does The Chemours Company pay dividends?
Yes, The Chemours Company pays dividends and its trailing 12-month yield is 5.88% with 216% payout ratio.It means that the company is paying a dividend greater than earnings. The last The Chemours Company stock dividend of $0.25 was paid on 15 Dec 2021.
-
How much money does The Chemours Company make?
The Chemours Company has a market capitalization of 2.61B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 11.29% to 6.03B US dollars.
-
What is The Chemours Company's stock symbol?
The Chemours Company is traded on the NYSE under the ticker symbol "CC".
-
What is The Chemours Company's primary industry?
Company operates in the Basic Materials sector and Chemicals - Specialty industry.
-
How do i buy shares of The Chemours Company?
Shares of The Chemours Company can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are The Chemours Company's key executives?
The Chemours Company's management team includes the following people:
- Mr. Mark E. Newman Chief Executive Officer, Pres & Director(age: 62, pay: $1,330,000)
- Mr. Sameer Ralhan Senior Vice President & Chief Financial Officer(age: 51, pay: $1,030,000)
- Mr. Edwin C. Sparks Pres of Titanium Technologies(age: 51, pay: $922,420)
- Mr. David C. Shelton Esq. Senior Vice President, Gen. Counsel & Corporation Sec.(age: 61, pay: $868,150)
-
How many employees does The Chemours Company have?
As Jul 2024, The Chemours Company employs 6,200 workers, which is 6% less then previous quarter.
-
When The Chemours Company went public?
The Chemours Company is publicly traded company for more then 10 years since IPO on 19 Jun 2015.
-
What is The Chemours Company's official website?
The official website for The Chemours Company is chemours.com.
-
Where are The Chemours Company's headquarters?
The Chemours Company is headquartered at 1007 Market Street, Wilmington, DE.
-
How can i contact The Chemours Company?
The Chemours Company's mailing address is 1007 Market Street, Wilmington, DE and company can be reached via phone at +30 27731000.
-
What is The Chemours Company stock forecast & price target?
Based on 2 Wall Street analysts` predicted price targets for The Chemours Company in the last 12 months, the avarage price target is $30. The average price target represents a 95.05% change from the last price of $15.38.
The Chemours Company company profile:
The Chemours Company
chemours.comExchange:
NYSE
Full time employees:
6,200
Industry:
Chemicals - Specialty
Sector:
Basic Materials
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and others applications. The Chemical Solutions segment comprises a portfolio of industrial chemicals used as raw materials and catalysts for gold production, clean and disinfect, oil and gas, water treatment, electronics, and automotive applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
1007 Market Street
Wilmington, DE 19899
Wilmington, DE 19899
CIK: 0001627223
ISIN: US1638511089
CUSIP: 163851108
